UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Exploring conservative management for cervical intraepithelial neoplasia grade 2 in organised cervical cancer screening programmes: a multicentre study in Italy

Family medicine and community health, 2024-02, Vol.12 (Suppl 2), p.e002595

2024

Volltextzugriff (PDF)

The immune microenvironment of HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma: a multiparametric quantitative and spatial analysis unveils a rationale to target treatment-naïve tumors with immune checkpoint inhibitors

Journal of experimental & clinical cancer research, 2022-09, Vol.41 (1), p.279-24, Article 279

2022

Volltextzugriff (PDF)

Performance of HPV E6/E7 mRNA assay as primary screening test: Results from the NTCC2 trial

International journal of cancer, 2022-10, Vol.151 (7), p.1047-1058

2022

Volltextzugriff (PDF)

Telomeres and telomerase in head and neck squamous cell carcinoma: from pathogenesis to clinical implications

Cancer and metastasis reviews, 2016-09, Vol.35 (3), p.457-474

2016

Volltextzugriff (PDF)

Detection of HPV16/18 E6 Oncoproteins in Head and Neck Squamous Cell Carcinoma Using a Protein Immunochromatographic Assay

The Laryngoscope, 2021-05, Vol.131 (5), p.1042-1048

2021

Volltextzugriff (PDF)

Leptomeningeal Carcinomatosis of a Poorly Differentiated Cervical Carcinoma Caused by Human Papillomavirus Type 18

Viruses, 2021-02, Vol.13 (2), p.307

2021

Volltextzugriff (PDF)

Acceptability of deferring the start of cervical cancer screening to age 30 for women vaccinated against human papillomavirus

Preventive medicine reports, 2023-12, Vol.36, p.102438-102438, Article 102438

2023

Volltextzugriff (PDF)

Rising Trend in the Prevalence of HPV-Driven Oropharyngeal Squamous Cell Carcinoma during 2000–2022 in Northeastern Italy: Implication for Using p16INK4a as a Surrogate Marker for HPV-Driven Carcinogenesis

Cancers, 2023-05, Vol.15 (9), p.2643

2023

Volltextzugriff (PDF)

Telomere shortening in mucosa surrounding the tumor: Biosensor of field cancerization and prognostic marker of mucosal failure in head and neck squamous cell carcinoma

Oral oncology, 2015-05, Vol.51 (5), p.500-507

2015

Volltextzugriff (PDF)

A Retrospective Cohort Study of Young Women Spontaneously Choosing to Be Vaccinated against HPV: Outcomes from Their First Cervical Cancer Screening Test

Viruses, 2021-03, Vol.13 (3), p.486

2021

Volltextzugriff (PDF)

Absence of disruptive TP53 mutations in high‐risk human papillomavirus‐driven neck squamous cell carcinoma of unknown primary

Head & neck, 2019-11, Vol.41 (11), p.3833-3841

2019

Volltextzugriff (PDF)

Type-specific human papillomavirus biological features: validated model-based estimates

PloS one, 2013-11, Vol.8 (11), p.e81171

2013

Volltextzugriff (PDF)

Avoiding Unnecessary Treatment of Cervical Intraepithelial Neoplasia Grade 2

Clinical infectious diseases, 2020-06, Vol.70 (12), p.2591-2592

Del Mistro, Annarosa

2020

Volltextzugriff (PDF)

Efficacy of self-sampling in promoting participation to cervical cancer screening also in subsequent round

Preventive medicine reports, 2017-03, Vol.5 (C), p.166-168

2017

Volltextzugriff (PDF)

Reproducibility of HPV DNA testing by hybrid capture 2 in a screening setting : Intralaboratory and interlaboratory quality control in seven laboratories participating in the same clinical trial

American journal of clinical pathology, 2005-11, Vol.124 (5), p.716-721

2005

Volltextzugriff (PDF)

hr-HPV testing in the management of women with ASC-US+ and in the follow-up of women with cytological abnormalities and negative colposcopy. Recommendations of the Italian group for cervical cancer screening (GISCi)

Epidemiologia e prevenzione, 2015-05, Vol.39 (3 Suppl 1), p.84

2015

Volltextzugriff (PDF)

HPV Genotyping in the Prevention of Cervical Cancer-How and When Can It Be a Useful Marker?

Cancer epidemiology, biomarkers & prevention, 2015-09, Vol.24 (9), p.1302-1303

Del Mistro, Annarosa

2015

Volltextzugriff (PDF)

Human papillomavirus typing of invasive cervical cancers in Italy

Infectious agents and cancer, 2006-12, Vol.1 (1), p.9-9, Article 9

2006

Volltextzugriff (PDF)

HPV testing for primary cervical screening: Laboratory issues and evolving requirements for robust quality assurance

Journal of clinical virology, 2016-03, Vol.76, p.S22-S28

2016

Volltextzugriff (PDF)

Rising Trend in the Prevalence of HPV-Driven Oropharyngeal Squamous Cell Carcinoma during 2000–2022 in Northeastern Italy: Implication for Using p16[sup.INK4a] as a Surrogate Marker for HPV-Driven Carcinogenesis

Cancers, 2023-05, Vol.15 (9)

2023

Volltextzugriff (PDF)

Cervical cancer screening in women vaccinated against human papillomavirus infection: Recommendations from a consensus conference

Preventive medicine, 2017-05, Vol.98, p.21-30

2017

Volltextzugriff (PDF)

Rising Trend in the Prevalence of HPV-Driven Oropharyngeal Squamous Cell Carcinoma during 2000-2022 in Northeastern Italy: Implication for Using p16 INK4a as a Surrogate Marker for HPV-Driven Carcinogenesis

Cancers, 2023-05, Vol.15 (9)

2023

Volltextzugriff (PDF)

Gene promoter methylation signature predicts survival of head and neck squamous cell carcinoma patients

Epigenetics, 2016-01, Vol.11 (1), p.61-73

2016

Volltextzugriff (PDF)

A prospective cohort study to identify biomarkers predicting the regression of grade 2 Cervical Intraepithelial Neoplasia. Study protocol

European journal of gynaecological oncology, 2021-10, Vol.42 (5), p.893

2021

Volltextzugriff (PDF)

ASC-US diagnosis and triage

Gynecologic oncology, 2007-10, Vol.107 (1), p.S2-S4

Del Mistro, Annarosa

2007

Volltextzugriff (PDF)

1 – 25 von 61

Suche als RSS-Feed

Aktive Filter

ThemaAdult

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(58)
Mit Volltextzugriff
(50)

Publikationsform

Artikel
(61)

Sprache

Englisch
(61)

Erscheinungsjahr

n.n

Thema

Science & Technology
(39)
Life Sciences & Biomedicine
(37)
Humans
(36)
Human Papillomavirus
(21)
Female
(19)
Oncology
(18)
Biological And Medical Sciences
(14)
Medical Sciences
(13)
Aids/hiv
(12)
Cervical Cancer
(9)
Cervical Cancer Screening
(8)
Squamous Cell Carcinoma
(8)
Hematology
(7)
Hpv
(7)
Male
(7)
Tumors
(7)
Uterine Cervical Neoplasms - Diagnosis
(7)
Cancer
(6)
Middle Aged
(6)
Virology
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Exploring conservative management for cervical intraepithelial neoplasia grade 2 in organised cervical cancer screening programmes: a multicentre study in Italy

The immune microenvironment of HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma: a multiparametric quantitative and spatial analysis unveils a rationale to target treatment-naïve tumors with immune checkpoint inhibitors

Performance of HPV E6/E7 mRNA assay as primary screening test: Results from the NTCC2 trial

Telomeres and telomerase in head and neck squamous cell carcinoma: from pathogenesis to clinical implications

Detection of HPV16/18 E6 Oncoproteins in Head and Neck Squamous Cell Carcinoma Using a Protein Immunochromatographic Assay

Leptomeningeal Carcinomatosis of a Poorly Differentiated Cervical Carcinoma Caused by Human Papillomavirus Type 18

Acceptability of deferring the start of cervical cancer screening to age 30 for women vaccinated against human papillomavirus

Rising Trend in the Prevalence of HPV-Driven Oropharyngeal Squamous Cell Carcinoma during 2000–2022 in Northeastern Italy: Implication for Using p16INK4a as a Surrogate Marker for HPV-Driven Carcinogenesis

Telomere shortening in mucosa surrounding the tumor: Biosensor of field cancerization and prognostic marker of mucosal failure in head and neck squamous cell carcinoma

A Retrospective Cohort Study of Young Women Spontaneously Choosing to Be Vaccinated against HPV: Outcomes from Their First Cervical Cancer Screening Test

Absence of disruptive TP53 mutations in high‐risk human papillomavirus‐driven neck squamous cell carcinoma of unknown primary

Type-specific human papillomavirus biological features: validated model-based estimates

Avoiding Unnecessary Treatment of Cervical Intraepithelial Neoplasia Grade 2

Efficacy of self-sampling in promoting participation to cervical cancer screening also in subsequent round

Reproducibility of HPV DNA testing by hybrid capture 2 in a screening setting : Intralaboratory and interlaboratory quality control in seven laboratories participating in the same clinical trial

hr-HPV testing in the management of women with ASC-US+ and in the follow-up of women with cytological abnormalities and negative colposcopy. Recommendations of the Italian group for cervical cancer screening (GISCi)

HPV Genotyping in the Prevention of Cervical Cancer-How and When Can It Be a Useful Marker?

Human papillomavirus typing of invasive cervical cancers in Italy

HPV testing for primary cervical screening: Laboratory issues and evolving requirements for robust quality assurance

Rising Trend in the Prevalence of HPV-Driven Oropharyngeal Squamous Cell Carcinoma during 2000–2022 in Northeastern Italy: Implication for Using p16[sup.INK4a] as a Surrogate Marker for HPV-Driven Carcinogenesis

Cervical cancer screening in women vaccinated against human papillomavirus infection: Recommendations from a consensus conference

Rising Trend in the Prevalence of HPV-Driven Oropharyngeal Squamous Cell Carcinoma during 2000-2022 in Northeastern Italy: Implication for Using p16 INK4a as a Surrogate Marker for HPV-Driven Carcinogenesis

Gene promoter methylation signature predicts survival of head and neck squamous cell carcinoma patients

A prospective cohort study to identify biomarkers predicting the regression of grade 2 Cervical Intraepithelial Neoplasia. Study protocol

ASC-US diagnosis and triage

Aktive Filter

Suchergebnisse filtern